Martin Chassany is counsel in the Corporate practice.

He focuses on mergers and acquisitions. He advises investment funds, listed and non-listed companies and their management teams on corporate transactions.

• BNP Paribas Personal Finance on the sale of BNP Paribas Personal Finance Bulgaria to Eurobank.
• Société Générale on its plan to form a joint venture with AllianceBernstein.
• Siparex and EMZ Partners on their investment in Batibig.
• Florac in connection with its investment in Dentius group.
• Mubadala in its investment in SGD Pharma alongside PAI Partners.
• Bpifrance and Mubadala in connection with the acquisition of a stake in Omni-PAC Group alongside Latour Capital and managers of the target.
• Bpifrance and Mubadala in connection with their participation in the Series B issuance of Matera.
• Florac on its investment in Salto (Spain).
• Florac, Kartesia and Ardian in connection with the sale of Brico Privé to the group les Mousquetaires.
• Celeste Management, Eurobail and Florac in connection with their investment in DocCity Group.
• ALD Automotive on its joint venture with Ford and launch of «Ford Fleet Management».
• Siparex on its investment in Batibig Group, a leading company specialized in the maintenance and renovation of buildings.
• CCI Lyon Metropole in connection with the envisaged equity investment in emlyon (one of the leading French business schools) by private equity fund Qualium Investment and French State-owned bank Bpifrance.
• A sovereign fund on its investment in Altice/SFR French telecom towers alongside KKR.
• Société Générale in connection with the restructuring of Eqdom.
• Dow Inc. (formerly The Dow Chemical Company) on its separation and spin-off from DowDuPont.
• First Eagle Investment Management LLC in connection with the sale of blocks of shares representing a 17.39% stake in French listed company Robertet. 
• Florac in connection with the acquisition of Brico Privé. 
• First Eagle Funds in connection with the sale of the Emin Leydier group to SAICA group.
• Amundi in connection with the direct and indirect disposal of interest in the fund SGAM AI Private Value Fund.
• Siparex in connection with its investment in NG Travel, a leading French tour operator.
• IMASCAP SAS in connection with its sale to Wright Medical Group for €75 million. 
  
   

Awards & Accolades

Martin Chassany is recognized as “Notable Practitioner” for M&A in France by IFLR1000 (2022)